WORCESTER, Mass., Nov. 4, 2008 (GLOBE NEWSWIRE) -- Generex Oral-lyn(tm) from Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, was featured this week at the 2nd IDF Regional MENA Diabetes Conference and 17th Annual Meeting of the Syrian Diabetes Association. The international conference of four hundred doctors and endocrinologists from throughout the Middle East and North Africa was held October 29-31 in Lattakia, Syria. Among a population of 300 million, MENA region countries have an average diabetes rate of over 20 percent.
